|
|
Article: Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent.
- Article from:
- Business Wire
- Article date:
- September 15, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Research Studies Will Enroll More Than 3,500 Patients at 200-Plus Investigational Sites Worldwide
MINNEAPOLIS -- Consistent with its commitment to advancing the treatment of cardiovascular disease through innovative product design and rigorous clinical research, Medtronic, Inc. (NYSE: MDT), announced today the start of two new trials of the Endeavor([R]) Resolute drug-eluting stent (DES), the company's innovative complement to the Endeavor drug-eluting stent, which was approved by the U.S. Food and Drug Administration (FDA) in February 2008.
Clinical research teams led by interventional cardiologists Dr. James Carr at East Texas Medical Center in the ...